What is Dabigatran?
Category: Prescription Drugs
Most popular types: Pradaxa Prazaxa
Dabigatran is an anticoagulant, thrombin inhibitor used for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation and postoperative thromboprophylaxis in patients who have undergone total hip or knee replacement procedures.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Prevent blood clotting | 26 | 13 | |
| Atrial fibrillation | 10 | 1 | |
| Irregular heartbeat (cardiac arrhythmia) | 7 | 7 | |
| Antiphospholipid antibody syndrome | 1 | 1 | |
| Chronic cerebrospinal venous insufficiency | 1 | 1 | |
| Deep vein thrombosis | 1 | 1 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 2 | |
| Mild | 1 | |
| None | 18 |
Commonly reported side effects and conditions associated with Dabigatran
| Side effect | Patients | Percentage |
|---|---|---|
| Bleed easily | 1 | |
| Bruising of chest | 1 | |
| Morning sleepiness | 1 | |
| Slow wound healing | 1 |
Duration
Stopped taking Dabigatran
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 2 | |
| 1 - 6 months | 7 | |
| 6 months - 1 year | 1 | |
| 1 - 2 years | 2 | |
| 5 - 10 years | 1 |
What people switch to and from
Patients started taking Dabigatran after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Warfarin (Coumadin) | 2 | |
| Acenocoumarol (Sintrom) | 1 | |
| Apixaban (Eliquis) | 1 |
Patients stopped taking Dabigatran and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Apixaban (Eliquis) | 1 | |
| Heparin | 1 | |
| Rivaroxaban (Xarelto) | 1 |
Last updated: